Omeros Stock

Omeros Current Ratio

The Current Ratio of Omeros (OMER) as of Aug 13, 2026 is 2.37. In the previous year, Current Ratio was 0.88 — a change of 171.00% (higher).

Current Ratio

2.37

YoY

171.00%

Last updated:

Current Ratio of Omeros is 2026 2.37 . Current Ratio of Omeros was 2025 0.88 . It decreases by 171.00% higher compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Current Ratio of Omeros is 2.37 in 2026.

Current Ratio of Omeros changed from 0.88 to 2.37, representing a 171.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Omeros since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Omeros with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Omeros

All Key Metrics — Omeros